ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.27% | 18.07% | 42.93% | 33.96% | 9.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.27% | 18.07% | 42.93% | 33.96% | 9.10% |
| Cost of Revenue | 53.82% | 13.97% | 30.39% | 33.13% | -0.43% |
| Gross Profit | 26.05% | 20.77% | 51.13% | 34.48% | 15.54% |
| SG&A Expenses | 26.25% | 66.36% | 47.95% | 19.05% | 10.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.20% | 41.82% | 40.67% | 16.77% | 6.45% |
| Operating Income | -20.02% | -80.35% | -37.56% | 6.94% | -2.29% |
| Income Before Tax | -26.87% | -95.72% | -58.85% | -43.63% | -18.61% |
| Income Tax Expenses | -150.00% | -252.00% | -55.56% | 112.50% | -42.86% |
| Earnings from Continuing Operations | -26.63% | -94.23% | -58.51% | -44.56% | -18.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.63% | -94.23% | -58.51% | -44.56% | -18.44% |
| EBIT | -20.02% | -80.35% | -37.56% | 6.94% | -2.29% |
| EBITDA | -15.60% | -87.15% | -35.07% | 8.69% | -6.46% |
| EPS Basic | -16.22% | -81.90% | -48.71% | -38.27% | -14.92% |
| Normalized Basic EPS | -16.47% | -83.42% | -49.00% | -5.62% | -15.04% |
| EPS Diluted | -16.22% | -81.90% | -48.71% | -38.27% | -14.92% |
| Normalized Diluted EPS | -16.47% | -83.42% | -49.00% | -5.62% | -15.04% |
| Average Basic Shares Outstanding | 8.99% | 6.75% | 6.59% | 4.56% | 3.03% |
| Average Diluted Shares Outstanding | 8.99% | 6.75% | 6.59% | 4.56% | 3.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |